tiprankstipranks
Advertisement
Advertisement

NURPF Stock Latest News

Neuren Updates Market on Ongoing On-Market Share Buy-Back
Company AnnouncementsNeuren Updates Market on Ongoing On-Market Share Buy-Back
1h ago
Neuren Pharmaceuticals Outlines Procedures for Virtual Shareholder Meeting
PremiumCompany Announcements
Neuren Pharmaceuticals Outlines Procedures for Virtual Shareholder Meeting
12d ago
Neuren Sets Hybrid 2026 AGM, Puts Director Re-election to Shareholder Vote
PremiumCompany Announcements
Neuren Sets Hybrid 2026 AGM, Puts Director Re-election to Shareholder Vote
12d ago
Neuren Files Updated ASX Governance Appendix, Confirms Compliance With Key Standards
PremiumCompany Announcements
Neuren Files Updated ASX Governance Appendix, Confirms Compliance With Key Standards
12d ago
Neuren details 2025 progress and governance in latest annual report
PremiumCompany Announcements
Neuren details 2025 progress and governance in latest annual report
12d ago
Neuren Updates Market on Ongoing On‑Market Share Buy‑Back
PremiumCompany AnnouncementsNeuren Updates Market on Ongoing On‑Market Share Buy‑Back
15d ago
Neuren Pharmaceuticals Updates Market on Ongoing Share Buy-Back
Premium
Company Announcements
Neuren Pharmaceuticals Updates Market on Ongoing Share Buy-Back
16d ago
Neuren Updates Market on Progress of On-Market Share Buy-Back
Premium
Company Announcements
Neuren Updates Market on Progress of On-Market Share Buy-Back
19d ago
Neuren Cancels Shares Following On-Market Buy-Back
PremiumCompany Announcements
Neuren Cancels Shares Following On-Market Buy-Back
26d ago
Neuren Expands Rett Syndrome Reach as DAYBUE STIX Goes Broadly U.S.-Available
PremiumCompany Announcements
Neuren Expands Rett Syndrome Reach as DAYBUE STIX Goes Broadly U.S.-Available
28d ago
Neuren Pharmaceuticals Reports Lapse of 50,000 Conditional Options
PremiumCompany Announcements
Neuren Pharmaceuticals Reports Lapse of 50,000 Conditional Options
1M ago
Neuren updates market on ongoing on‑market share buy‑back
PremiumCompany Announcements
Neuren updates market on ongoing on‑market share buy‑back
1M ago
Neuren Updates Market on Ongoing On-Market Share Buy-Back
PremiumCompany AnnouncementsNeuren Updates Market on Ongoing On-Market Share Buy-Back
2M ago
Neuren director Joseph Basile lifts stake with on-market share purchase
Premium
Company Announcements
Neuren director Joseph Basile lifts stake with on-market share purchase
2M ago
Neuren backs Acadia’s EMA appeal after CHMP rejection of Rett drug trofinetide
Premium
Company Announcements
Neuren backs Acadia’s EMA appeal after CHMP rejection of Rett drug trofinetide
2M ago
Neuren Highlights Neurodevelopmental Focus and Development Risks in Investor Update
PremiumCompany Announcements
Neuren Highlights Neurodevelopmental Focus and Development Risks in Investor Update
2M ago
Neuren Builds Cash and Pipeline as DAYBUE Royalties Climb in 2025
PremiumCompany Announcements
Neuren Builds Cash and Pipeline as DAYBUE Royalties Climb in 2025
2M ago
Neuren profit falls on absence of one-offs as core royalties and R&D spend climb
PremiumCompany Announcements
Neuren profit falls on absence of one-offs as core royalties and R&D spend climb
2M ago
Neuren Rides DAYBUE Growth as 2025 Royalties Climb and 2026 Outlook Strengthens
PremiumCompany Announcements
Neuren Rides DAYBUE Growth as 2025 Royalties Climb and 2026 Outlook Strengthens
2M ago
Neuren Pharmaceuticals Launches On-Market Share Buy-Back
PremiumCompany AnnouncementsNeuren Pharmaceuticals Launches On-Market Share Buy-Back
3M ago
Neuren Schedules Investor Webinar as Rare Neurology Portfolio Advances
Premium
Company Announcements
Neuren Schedules Investor Webinar as Rare Neurology Portfolio Advances
3M ago
Neuren launches on-market buy-back as board flags undervalued shares
Premium
Company Announcements
Neuren launches on-market buy-back as board flags undervalued shares
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >